Literature Collection

7841

Operational Lessons from a Large Accountable Care Organization

Type: Journal Article

Authors: Sreekanth K. Chaguturu, Margaret Costello, David Connolly, Gary L. Gottlcib, Timothy G. Ferris

Year: 2014

Topic(s):

Export Citation: RIS

View details

7842

Operational Tools and Best Practices to Support Electronic Health Record-Sourced Data Quality, Relevance, and Reliability at the Data Accrual Phase

Type: Government Report

Authors: Matthew D'Ambrosio, Patrick Rodriguez, Nora Emmott, Rachele Hendricks-Sturrup

Year: 2025

Publication Place: Durham, NC

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (628 KB)

Reference Links: PDF (628 KB)

Export Citation: RIS

View details

7843

Operationalization of biopsychosocial case complexity in general health care: the INTERMED project

Type: Journal Article

Authors: P. de Jonge, F. J. Huyse, J. P. Slaets, W. Sollner, F. C. Stiefel

Year: 2005

Publication Place: Australia

Abstract: OBJECTIVE: Lack of operationalization of the biopsychosocial model hinders its effective application to the increasingly prevalent problems of comorbidities in clinical presentations. Here, we describe the INTERMED, an instrument to assess biopsychosocial case complexity in general health care, and provide an overview of its psychometric evaluation. METHOD: Review and summary of our publications to date, and re-analysis of findings. RESULTS: The INTERMED has face-validity, is brief and easy to use, and several research reports support its reliability and validity. It has the capacity to detect patients at risk for poor clinical outcome and quality of life. CONCLUSIONS: The INTERMED project is relevant to various agents involved in the care process. It provides a basis for effective multidisciplinary treatment of patients with a high case complexity.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7844

Operationalizing Accountability for Integrated Care: A Qualitative Study of an Ontario Health Team

Type: Journal Article

Authors: N. Farhana, K. Rego, J. M. Evans

Year: 2025

Abstract:

Shared accountability is widely emphasized in integrated care theory and policy but remains underspecified in practice. This study examined how shared accountability was operationalized and experienced within an Ontario Health Team (OHT) using data from 23 semi-structured interviews with OHT stakeholders. Six interrelated factors that shape shared accountability were identified: perceived organizational identity, clarity of leadership roles and consequences for non-compliance, clarity of partner organizations' roles and consequences for non-compliance, management of goals and interests, trust and psychological safety, and power dynamics. Together, these factors highlight that shared accountability is not merely a matter of assigning roles or measuring outcomes; rather, it is a complex, relational process. These findings offer practical guidance for strengthening shared accountability in integrated care networks.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7845

Operationalizing integrated care on a clinical level: the INTERMED project

Type: Journal Article

Authors: F. C. Stiefel, F. J. Huyse, W. Sollner, J. P. Slaets, J. S. Lyons, C. H. Latour, N. van der Wal, P. de Jonge

Year: 2006

Publication Place: United States

Abstract: During the last 10 years the INTERMED method has been developed as a generic method for the assessment of bio-psychosocial health risks and health needs and for planning of integrated treatment. The INTERMED has been conceptualized to counteract divisions and fragmentation of medical care. Designed to enhance the communication between patients and the health providers as well as between different professions and disciplines, the INTERMED is a visualized, action-oriented decision-support tool. This article presents various aspects of the INTERMED, such as its relevance, description, scoring, the related patient interview and treatment planning, scientific evaluation, implementation, and support for the method.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7846

Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision

Type: Journal Article

Authors: T. Barry, J. Klimas, H. Tobin, M. Egan, G. Bury

Year: 2017

Publication Place: England

Topic(s):

Reference Links:

Export Citation: RIS

View details

7847

Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon

Type: Journal Article

Authors: A. Ghaddar, Z. Abbas, R. Haddad

Year: 2017

Publication Place: England

Abstract: BACKGROUND: Opioid agonist therapy has been widely used to reduce harms among individuals with opioid use disorder but its effectiveness has not been evaluated in the Middle East North African (MENA) region. This study aims to evaluate the effectiveness of a program using opioid agonist therapy in combination with psychosocial support on improving psychological and social well-being, reducing arrest, and reducing risky behavior in individuals with opioid use disorder in Lebanon. METHODS: A one-group pre-test post-test design study was performed at SKOUN Lebanese Addiction Centre between January 2013 and December 2014. Eighty-six out of 181 patients agreed to participate and completed the 3-month assessment and 38 concluded the 12-month assessment. Psychological (depression and anxiety, quality of life), substance dependence/abuse, behavioral (injecting behavior, sharing needles and paraphernalia), and social outcomes were evaluated at baseline, 3, and 12 months post-treatment. RESULTS: Remarkable statistical significance improvements were observed 3 months after treatment in most outcome variables including quality of life, anxiety, substance dependence, overdose, employment, and injecting behavior. Improvements were sustained 12 months after treatment. CONCLUSION: Results support expanding the access to opioid agonist therapy in other MENA countries to treat substance dependence and reduce harms among individuals with opioid use disorder.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7848

Opiate dependence or addiction?: A review of the centers for disease control and prevention guidelines for management of chronic pain

Type: Journal Article

Authors: Gina C. Dobbs, Susanne A. Fogger

Year: 2018

Topic(s):

, ,

Reference Links:

Export Citation: RIS

View details

7849

Opiate substitution treatment to reduce in-prison drug injection: A natural experiment

Type: Journal Article

Authors: Stuart A. Kinner, Elizabeth Moore, Matthew J. Spittal, Devon Indig

Year: 2013

Publication Place: Amsterdam

Topic(s):

,

Export Citation: RIS

View details

7850

Opiate use disorders and overdose: Medical students' experiences, satisfaction with learning, and attitudes toward community naloxone provision

Type: Journal Article

Authors: H. Tobin, J. Klimas, T. Barry, M. Egan, G. Bury

Year: 2018

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

7851

Opioid Abuse in the U.S. and HHS Actions to Address Opioid-Drug Related Overdoses and Deaths

Type: Government Report

Authors: Office of the Assistant Secretary for Planning and Evaluation

Year: 2015

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

PDF (147.58 KB)

Reference Links: PDF (147.58 KB)

Export Citation: RIS

View details

7852

Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options

Type: Journal Article

Authors: J. Bonhomme, R. S. Shim, R. Gooden, D. Tyus, G. Rust

Year: 2012

Publication Place: United States

Abstract: Opioid abuse and addiction have increased in frequency in the United States over the past 20 years. In 2009, an estimated 5.3 million persons used opioid medications nonmedically within the past month, 200000 used heroin, and approximately 9.6% of African Americans used an illicit drug. Racial and ethnic minorities experience disparities in availability and access to mental health care, including substance use disorders. Primary care practitioners are often called upon to differentiate between appropriate, medically indicated opioid use in pain management vs inappropriate abuse or addiction. Racial and ethnic minority populations tend to favor primary care treatment settings over specialty mental health settings. Recent therapeutic advances allow patients requiring specialized treatment for opioid abuse and addiction to be managed in primary care settings. The Drug Addiction Treatment Act of 2000 enables qualified physicians with readily available short-term training to treat opioid-dependent patients with buprenorphine in an office-based setting, potentially making primary care physicians active partners in the diagnosis and treatment of opioid use disorders. Methadone and buprenorphine are effective opioid replacement agents for maintenance and/or detoxification of opioid-addicted individuals. However, restrictive federal regulations and stigmatization of opioid addiction and treatment have limited the availability of methadone. The opioid partial agonist-antagonist buprenorphine/naloxone combination has proven an effective alternative. This article reviews the literature on differences between buprenorphine and methadone regarding availability, efficacy, safety, side-effects, and dosing, identifying resources for enhancing the effectiveness of medication-assisted recovery through coordination with behavioral/psychological counseling, embedded in the context of recovery-oriented systems of care.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7853

Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?

Type: Journal Article

Authors: L. Hensley, S. Sulo, S. Kozmic, B. V. Parilla

Year: 2018

Publication Place: United States

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

7854

Opioid addiction screening tools for patients with chronic noncancer pain

Type: Journal Article

Authors: A. M. dela Cruz, M. H. Trivedi

Year: 2015

Publication Place: United States

Topic(s):

,

Reference Links:

Export Citation: RIS

View details

7855

Opioid Addiction Treatment

Type: Web Resource

Authors: The University of New Mexico

Year: 2021

Publication Place: Project ECHO, The University of New Mexico

Topic(s):

, ,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

7856

Opioid Addiction Treatment: A Guide for Patients, Families, and Friends

Type: Report

Authors: American Society of Addiction Medicine

Year: 2016

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

7857

Opioid Addiction With Psychiatric Comorbidities

Type: Web Resource

Authors: Providers Clinical Support System

Year: 2021

Topic(s):

,

Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

Access Resource

Reference Links: Access Resource

Export Citation: RIS

View details

7858

Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption

Type: Journal Article

Authors: M. C. Beneitez, M. E. Gil-Alegre

Year: 2017

Publication Place: United States

Abstract: BACKGROUND: Detoxification programmes seek to implement the most secure and compassionate ways of withdrawing from opiates so that the inevitable withdrawal symptoms and other complications are minimized. Once detoxification has been achieved, the next stage is to enable the patient to overcome his or her drug addiction by ensuring consumption is permanently and completely abandoned, only after which can the subject be regarded as fully recovered. METHODS: A systematic search on the common databases of relevant papers published until 2016 inclusive. RESULTS AND CONCLUSION: Our study of the available oral treatments for opioid dependence has revealed that no current treatment can actually claim to be fully effective. These treatments require daily oral administration and, consequently, regular visits to dispensaries, which in most cases results in a lack of patient compliance, which causes fluctuations in drug plasma levels. We then reviewed alternative treatments in the available scientific literature on polymeric sustained release formulations. Research has been done not only on release systems for detoxification but also on release systems for giving up the habit of taking opioids. These efforts have obtained the recent authorization of polymeric systems for use in patients that could help them to reduce their craving for drugs.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7859

Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption

Type: Journal Article

Authors: M. C. Beneitez, M. E. Gil-Alegre

Year: 2017

Publication Place: United States

Abstract: BACKGROUND: Detoxification programmes seek to implement the most secure and compassionate ways of withdrawing from opiates so that the inevitable withdrawal symptoms and other complications are minimized. Once detoxification has been achieved, the next stage is to enable the patient to overcome his or her drug addiction by ensuring consumption is permanently and completely abandoned, only after which can the subject be regarded as fully recovered. METHODS: A systematic search on the common databases of relevant papers published until 2016 inclusive. RESULTS AND CONCLUSION: Our study of the available oral treatments for opioid dependence has revealed that no current treatment can actually claim to be fully effective. These treatments require daily oral administration and, consequently, regular visits to dispensaries, which in most cases results in a lack of patient compliance, which causes fluctuations in drug plasma levels. We then reviewed alternative treatments in the available scientific literature on polymeric sustained release formulations. Research has been done not only on release systems for detoxification but also on release systems for giving up the habit of taking opioids. These efforts have obtained the recent authorization of polymeric systems for use in patients that could help them to reduce their craving for drugs.

Topic(s):

Reference Links:

Export Citation: RIS

View details

7860

Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series

Type: Journal Article

Authors: S. Nielsen, R. Bruno, L. Degenhardt, A. Demirkol, N. Lintzeris

Year: 2016

Topic(s):

Reference Links:

Export Citation: RIS

View details